Short Interest in XOMA Co. (NASDAQ:XOMAO) Rises By 3,209.1%

XOMA Co. (NASDAQ:XOMAO) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totaling 11,615 shares, a growth of 3,209.1% from the November 30th total of 351 shares. Based on an average trading volume of 23,708 shares, the days-to-cover ratio is presently 0.5 days. Based on an average trading volume of 23,708 shares, the days-to-cover ratio is presently 0.5 days.

XOMA Stock Performance

Shares of XOMA stock traded up $0.02 during trading hours on Wednesday, reaching $25.55. The stock had a trading volume of 759 shares, compared to its average volume of 3,788. XOMA has a 1 year low of $23.32 and a 1 year high of $25.76. The firm has a 50 day simple moving average of $25.41 and a two-hundred day simple moving average of $25.43.

XOMA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5234 per share. This represents a $2.09 annualized dividend and a yield of 8.2%. The ex-dividend date is Friday, January 2nd.

XOMA Company Profile

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.